南京医药(600713) - 2017 Q1 - 季度财报
NPCNPC(SH:600713)2017-04-28 16:00

Financial Performance - Net profit attributable to shareholders rose by 20.88% to CNY 59,899,871.16 year-on-year[5] - Basic earnings per share increased by 21.82% to CNY 0.067[5] - The weighted average return on equity improved by 0.125 percentage points to 2.255%[5] - The company reported no significant changes in net profit compared to the same period last year, indicating stability in financial performance[28] - Net profit for Q1 2017 reached CNY 74,102,117.20, representing a 21.06% increase from CNY 61,198,472.94 in Q1 2016[42] - The net profit attributable to shareholders of the parent company was CNY 59,899,871.16, up from CNY 49,551,623.41, marking a growth of 20.06%[42] Revenue and Costs - Operating revenue increased by 1.68% to CNY 6,682,714,328.28 compared to the same period last year[5] - Total operating revenue for Q1 2017 was CNY 6,682,714,328.28, an increase of 1.67% compared to CNY 6,572,216,250.79 in the same period last year[41] - Total operating costs for Q1 2017 were CNY 6,580,245,068.06, up from CNY 6,490,896,255.81, reflecting a year-over-year increase of 1.67%[42] Assets and Liabilities - Total assets increased by 7.66% to CNY 15,031,565,536.44 compared to the end of the previous year[5] - The company's total liabilities amounted to approximately RMB 11.89 billion, an increase of 9.1% from RMB 10.89 billion at the start of the year[34] - Current liabilities totaled CNY 6,644,458,761.42, an increase from CNY 5,690,406,284.46, reflecting a rise of 16.74%[38] - Accounts receivable reached approximately RMB 7.48 billion, up 15.8% from RMB 6.46 billion at the start of the year[32] - Inventory stood at approximately RMB 2.69 billion, reflecting an increase of 4.6% from RMB 2.57 billion at the beginning of the year[32] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 998,777,430.08, compared to a net outflow of CNY 600,559,015.27 in the same period last year[5] - The net cash flow from operating activities decreased year-on-year, totaling -¥998,777,430.08, mainly due to industry policy impacts and increases in accounts receivable and inventory[16] - The net cash flow from financing activities increased by 72.36% year-on-year, reaching ¥1,099,498,958.46, primarily due to new borrowings[16] - The cash flow from operating activities showed a net outflow of ¥998,777,430.08, worsening from a net outflow of ¥600,559,015.27 in the previous period[49] Investments and Financing - The company issued a total of ¥4 billion in short-term financing bonds with a coupon rate of 3.36% and a term of 366 days[18] - The company is actively promoting a non-public stock issuance plan, which has been approved by relevant authorities[19] - The company received government subsidies amounting to CNY 887,000.00 during the reporting period[12] - The company recorded a significant increase in sales revenue from services, amounting to ¥5,706,024,673.33, compared to ¥5,464,464,652.58 in the previous period[48] - The company has made investments totaling ¥697,794,777.59 during the current period, reflecting ongoing investment activities despite cash flow challenges[52] Construction and Expansion - The company has commenced construction on the new logistics center in Fujian, with a total investment of approximately RMB 170 million and a building area of about 34,500 square meters[25] - The company is actively expanding its logistics capabilities to enhance operational efficiency and support future growth initiatives[25] Tax and Impairment - The company's tax and additional fees increased by 54.13% year-on-year, amounting to ¥9,139,381.65[14] - Income tax expenses rose by 34.29% year-on-year, reaching ¥28,674,129.43, attributed to an increase in total profit[14] - Asset impairment losses decreased by 58.06% year-on-year, totaling ¥4,866,230.57, primarily due to the recovery of long-aged accounts receivable[14]